Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe, and Homi Bhabha National Institute, Mumbai, India.
Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe, and Homi Bhabha National Institute, Mumbai, India
J Nucl Med Technol. 2024 Jun 5;52(2):175-176. doi: 10.2967/jnmt.122.265385.
Malignancy in struma ovarii is rare and observed in only 5%-10% of patients. Here, we present a patient with malignant struma ovarii and coexisting intrathyroidal papillary thyroid carcinoma, with recurrence (large pouch-of-Douglas mass) and metastases (bilateral pulmonary and iliac nodal metastases) presenting 12 y after surgery. The notable features in this case were a concurrent intrathyroidal follicular variant of papillary carcinoma; the highly functioning nature of the malignant lesions, characterized by a low level of thyroid-stimulating hormone even without thyroxine suppression; and the low-grade F-FDG avidity of these lesions, consistent with their well-differentiated nature. With the adoption of a multimodality approach (surgery, radioiodine scintigraphic evaluation, and multiple radioiodine therapies), the patient showed a progressive decrease in the functionality of the disease, prolonged progression-free survival, and a good quality of life with symptom-free status at 5 y.
卵巢甲状腺肿的恶性肿瘤较为罕见,仅见于 5%-10%的患者。在此,我们报告 1 例恶性卵巢甲状腺肿合并甲状腺内乳头状癌的患者,该患者术后 12 年出现复发(大Douglas 窝肿块)和转移(双侧肺和髂淋巴结转移)。该病例的显著特征为同时存在甲状腺内滤泡型乳头状癌;恶性肿瘤具有高度功能性,即使未进行甲状腺素抑制治疗,促甲状腺激素水平也很低;这些病灶的 F-FDG 摄取率较低,与其良好分化的性质一致。通过采用多模态方法(手术、放射性碘闪烁显像评估和多次放射性碘治疗),患者的疾病功能逐渐下降,无进展生存期延长,生活质量良好,无症状状态持续 5 年。